HEATHER HECK: Open Payments
NPI 1407223944 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 18 payments from 10 companies in 2025. Trend: 2023 $7,710 · 2024 $6,565 · 2025 $474
Food & beverage: $375Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $99 |
| Novo Nordisk Inc | 4 | $79 |
| Corcept Therapeutics | 1 | $62 |
| Ascendis Pharma Endocrinology Inc | 2 | $53 |
| Dexcom, Inc. | 3 | $51 |
| Abbott Laboratories | 3 | $51 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| CeQur Corporation | 1 | $15 |
Products named: Korlym, Yorvipath, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Wegovy, TZIELD, ISTURISA, JARDIANCE.
Industry payments across CA — which companies pay providers there.
